PLIVA d.d. Company Description
PLIVA wants you to remember its scientific research and business acumen, and less the names of its products. PLIVA d.d. serves as the European headquarters of its parent company Barr Pharmaceuticals. The company develops and produces generic pharmaceuticals, particularly in the anti-inflammatory and anti-infective areas. PLIVA also produces the active pharmaceutical ingredients used by other drug makers. Its products include both prescription and over-the-counter drugs, pills, creams, and injectables. PLIVA was founded in 1921 and operates in more than 30 countries. While Barr holds 94% of the company, PLIVA remains publicly traded on the Zagreb Stock Exchange.
View the Comprehensive Company Description for PLIVA d.d.
The Company Description provides a historical perspective of PLIVA d.d.'s organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of PLIVA d.d.'s evolution in the marketplace.
